Shariah screening · sector
Halal Healthcare Stocks
681 Healthcare issuers carry a screening verdict, out of 1,750 issuers we hold in this sector. Verdicts come from two independent engines and each row says which.
Verdict split
449 compliant 26%
232 non-compliant 13%1 questionable 0%
1,068 no verdict yet 61%
450 screened by our own engine against published ratio methodologies computed from primary filings · 326 carrying a reviewed third-party provider verdict.
Screened issuers
Compliant first, then alphabetical. Every row links to that issuer's full ratio breakdown, business-activity screen and the filing behind it.
| Issuer | Verdict | Screened | Source |
|---|---|---|---|
| MYO MYO | NO VERDICT | — | not screened yet |
| 9887.HK Nanjing Leads Biolabs Co., Ltd. | NON-COMPLIANT | 2026-08-28 | in-house |
| 600682.SS Nanjing Xinjiekou Department Store Co., Ltd. | NON-COMPLIANT | 2026-08-26 | in-house |
| NASC NASC | NO VERDICT | — | not screened yet |
| NATCOPHARM.NS NATCO Pharma Limited | NON-COMPLIANT | 2026-08-26 | in-house |
| NAUT NAUT | NO VERDICT | — | not screened yet |
| NBRVF NBRVF | NO VERDICT | — | not screened yet |
| NCEL NCEL | NO VERDICT | — | not screened yet |
| NCNA NCNA | NO VERDICT | — | not screened yet |
| NECLIFE.NS Nectar Lifesciences Limited | UNRATED | 2026-08-28 | in-house |
| NEOG NEOG | NO VERDICT | — | not screened yet |
| NEPTF Neptune Wellness Solutions Inc. | UNRATED | 2026-08-28 | in-house |
| NERV NERV | NO VERDICT | — | not screened yet |
| NEUP NEUP | NO VERDICT | — | not screened yet |
| NEU.AX Neuren Pharmaceuticals Limited | NON-COMPLIANT | 2026-08-28 | in-house |
| NRSN NeuroSense Therapeutics Ltd. | UNRATED | 2026-08-28 | in-house |
| NAMS NewAmsterdam Pharma Company N.V. | UNRATED | 2026-08-28 | in-house |
| NGEN NGEN | NO VERDICT | — | not screened yet |
| NGHLF NGHLF | NO VERDICT | — | not screened yet |
| NGNE NGNE | NO VERDICT | — | not screened yet |
| NIKA NIKA | NO VERDICT | — | not screened yet |
| NIKI NIKI | NO VERDICT | — | not screened yet |
| NKTR NKTR | NO VERDICT | — | not screened yet |
| NKTX NKTX | NO VERDICT | — | not screened yet |
| NMRA NMRA | NO VERDICT | — | not screened yet |
| NNOX NNOX | NO VERDICT | — | not screened yet |
| NNVC NNVC | NO VERDICT | — | not screened yet |
| 600812.SS North China Pharmaceutical Company.Ltd | NON-COMPLIANT | 2026-08-26 | in-house |
| NBP NovaBridge Biosciences | NON-COMPLIANT | 2026-08-28 | in-house |
| NVCR NovoCure Ltd | NON-COMPLIANT | 2026-11-02 | provider |
| NPHC NPHC | NO VERDICT | — | not screened yet |
| NRIX NRIX | NO VERDICT | — | not screened yet |
| NSPR NSPR | NO VERDICT | — | not screened yet |
| NSTM NSTM | NO VERDICT | — | not screened yet |
| NTHI NTHI | NO VERDICT | — | not screened yet |
| NTLA NTLA | NO VERDICT | — | not screened yet |
| NTRB NTRB | NO VERDICT | — | not screened yet |
| NTRR NTRR | NO VERDICT | — | not screened yet |
| NUMD NUMD | NO VERDICT | — | not screened yet |
| NUNZ NUNZ | NO VERDICT | — | not screened yet |
| NUVB NUVB | NO VERDICT | — | not screened yet |
| NUWE NUWE | NO VERDICT | — | not screened yet |
| NVAX NVAX | NO VERDICT | — | not screened yet |
| NVCT NVCT | NO VERDICT | — | not screened yet |
| NVNO NVNO | NO VERDICT | — | not screened yet |
| 4565.T Nxera Pharma Co., Ltd. | NON-COMPLIANT | 2026-08-26 | in-house |
| NXGL NXGL | NO VERDICT | — | not screened yet |
| NXL NXL | NO VERDICT | — | not screened yet |
| NXTC NXTC | NO VERDICT | — | not screened yet |
| NYKD.OL Nykode Therapeutics AS | UNRATED | 2026-08-28 | in-house |
| NYMXF NYMXF | NO VERDICT | — | not screened yet |
| NYXH Nyxoah SA | NON-COMPLIANT | 2026-10-08 | provider |
| NYXH.BR Nyxoah SA | UNRATED | 2026-08-28 | in-house |
| OABI OABI | NO VERDICT | — | not screened yet |
| OBIO OBIO | NO VERDICT | — | not screened yet |
| OBX OBX | NO VERDICT | — | not screened yet |
| OCEA OCEA | NO VERDICT | — | not screened yet |
| OCGN OCGN | NO VERDICT | — | not screened yet |
| OCUL OCUL | NO VERDICT | — | not screened yet |
| OCS Oculis Holding AG | UNRATED | 2026-08-28 | in-house |
| ODTX ODTX | NO VERDICT | — | not screened yet |
| ODYY ODYY | NO VERDICT | — | not screened yet |
| OFIX OFIX | NO VERDICT | — | not screened yet |
| OGEN OGEN | NO VERDICT | — | not screened yet |
| OGI OGI | NO VERDICT | — | not screened yet |
| OHCFF OHCFF | NO VERDICT | — | not screened yet |
| OJSY OJSY | NO VERDICT | — | not screened yet |
| OKUR OKUR | NO VERDICT | — | not screened yet |
| OKYO OKYO Pharma Limited | UNRATED | 2026-08-28 | in-house |
| OLMA OLMA | NO VERDICT | — | not screened yet |
| OLYMY OLYMY | NO VERDICT | — | not screened yet |
| OM OM | NO VERDICT | — | not screened yet |
| OMER OMER | NO VERDICT | — | not screened yet |
| ONCO.ST Oncopeptides AB (publ) | NON-COMPLIANT | 2026-09-08 | in-house |
| ONCY ONCY | NO VERDICT | — | not screened yet |
| ONSS ONSS | NO VERDICT | — | not screened yet |
| ONWD.BR Onward Medical N.V. | NON-COMPLIANT | 2026-08-28 | in-house |
| ONWRF ONWRF | NO VERDICT | — | not screened yet |
| OPHLF OPHLF | NO VERDICT | — | not screened yet |
| OPHLY OPHLY | NO VERDICT | — | not screened yet |
| OPK Opko Health Inc | NON-COMPLIANT | 2026-10-08 | provider |
| IRD Opus Genetics, Inc. Common Stock | NON-COMPLIANT | 2026-10-08 | provider |
| ORMP Oramed Pharmaceuticals Inc. | UNRATED | 2026-08-28 | in-house |
| ORX.ST Orexo AB (publ) | NON-COMPLIANT | 2026-08-27 | in-house |
| OGI.TO Organigram Global Inc. | UNRATED | 2026-08-28 | in-house |
| ORGO ORGO | NO VERDICT | — | not screened yet |
| ORGS ORGS | NO VERDICT | — | not screened yet |
| ORIOLA.HE Oriola Oyj | NON-COMPLIANT | 2026-08-27 | in-house |
| ORKA ORKA | NO VERDICT | — | not screened yet |
| ORY.MC Oryzon Genomics S.A. | UNRATED | 2026-08-28 | in-house |
| OSE.PA OSE Immunotherapeutics SA | NON-COMPLIANT | 2026-08-27 | in-house |
| OSRH OSRH | NO VERDICT | — | not screened yet |
| OSTX OSTX | NO VERDICT | — | not screened yet |
| OSUR OSUR | NO VERDICT | — | not screened yet |
| OTLC OTLC | NO VERDICT | — | not screened yet |
| OTLK OTLK | NO VERDICT | — | not screened yet |
| OBCK.F Ottobock SE & Co. KGaA | NON-COMPLIANT | 2026-08-28 | in-house |
| OVID OVID | NO VERDICT | — | not screened yet |
| OWPC OWPC | NO VERDICT | — | not screened yet |
| OXB.L Oxford Biomedica plc | NON-COMPLIANT | 2026-08-27 | in-house |
Showing 1,301–1,400 of 1,750
Industries in Healthcare
11 industries under this sector, ordered by how many of their issuers carry a decided verdict.
Biotechnology
58 compliant of 148 decided, 607 not screened yet.
Drug Manufacturers - Specialty & Generic
96 compliant of 133 decided, 140 not screened yet.
Medical Devices
34 compliant of 54 decided, 111 not screened yet.
Diagnostics & Research
27 compliant of 37 decided, 21 not screened yet.
Medical Care Facilities
24 compliant of 35 decided, 39 not screened yet.
Medical Instruments & Supplies
16 compliant of 24 decided, 37 not screened yet.
Health Information Services
14 compliant of 19 decided, 58 not screened yet.
Drug Manufacturers - General
15 compliant of 18 decided, 11 not screened yet.
Pharmaceutical Retailers
4 compliant of 13 decided, 18 not screened yet.
Medical Distribution
5 compliant of 12 decided, 13 not screened yet.
Healthcare Plans
2 compliant of 3 decided, 4 not screened yet.